Furthermore, by proteomics and analytical chemistry-integrated approaches we demonstrated that Acod1 ablation opposes the urea cycle dysfunction promoted by liver steatosis, known to play an instrumental role in the progression of NAFLD [25, 26]. The gene discussed is ACOD1; the disease is Hepatic steatosis.